Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Signs and Symptoms 1Psoriasis 1Nutrition Disorders 1Insulin Resistance 1Inflammatory Bowel Diseases 1Glioma 1Glioblastoma 1Gastroparesis 1Feeding and Eating Disorders 1Esophageal Neoplasms 1Dumping Syndrome 1Diarrhea 1Breast Neoplasms 1Brain Neoplasms 1Arthritis, Rheumatoid 1

Interventions

Irinotecan 4Octreotide 3Probiotics 2Leucovorin 2Fluorouracil 2shosaiko-to 1maltodextrin 1lanreotide 1isatuximab 1bile acid binding proteins 1Temozolomide 1Sulfasalazine 1Raloxifene Hydrochloride 1Radiation 1Oxaliplatin 1Loperamide 1Long-Term Synaptic Depression 1Levofloxacin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Diet Therapy 1Cyclophosphamide 1Colesevelam Hydrochloride 1Celecoxib 1Cefpodoxime 1Cefixime 1Calcium Aluminosilicate 1Anti-Bacterial Agents 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diarrhea × Sulfasalazine × Clear all
NCT01198145 2020-05-12

Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
87 enrolled 11 charts

Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡